Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.
about
Sex Differences in Behavioral Dyscontrol: Role in Drug Addiction and Novel TreatmentsNegative affective states and cognitive impairments in nicotine dependenceDonepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice.Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.Mouse models for studying genetic influences on factors determining smoking cessation success in humans.Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning.Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity.Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapiesWithdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice.Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioningSex differences in reinstatement of cocaine-seeking with combination treatments of progesterone and atomoxetineCognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.Transdisciplinary Tobacco Use Research Centers: research achievements and future implications.Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response.Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism.Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
P2860
Q26768148-DB5A06C0-2510-46ED-BDC8-71F1A03647F3Q30371220-0471FE76-9760-43C5-8627-9F4C525D5860Q30401708-B1CD0C08-A559-442C-890F-83D7530EF491Q30422037-C28E3CDA-C743-4F0E-946D-9A4022570023Q30432964-6323F93D-1F13-4ADC-A982-262FE50C233CQ30448530-5A68ADBB-D893-42D8-8561-A3624F28B947Q30455930-14289414-EAD9-4E05-9F02-BD4C5AF5D39CQ30459642-8CEE71D5-8595-4D68-9108-477F79857692Q30463325-1C92DE45-CF22-44C1-B257-0B5C361E9BE5Q30480193-4B984A0C-10F6-43F7-A3C8-7F9D1CBE44B4Q30485478-FDC7FA30-1D8C-4F7F-8A1D-BB5310FD2E1DQ30489625-09BCF633-770E-4119-953A-89321C80EED8Q30491573-AC25A5CC-1A97-4170-8383-AE5551204010Q34870758-0C6F3D28-2BA4-4296-90A6-3C081296EC17Q35117860-B0592B95-99E7-4523-8A71-6048098FDF3FQ35694111-538916D0-3AAE-44FE-BD5A-BCB64B5DFBBFQ35785041-4FAECDD3-31E0-4215-932D-9BCAE4FFBD0CQ36103496-434CEF68-57E0-4125-9698-297B2989EDFCQ36892871-142D49D8-0FC1-4022-B16A-1E2632845B1BQ37188764-F2BAE927-6C85-4679-8AD4-79614D463625Q37195457-ADD46921-C62E-499F-B559-8C9D0B9C9076Q37353353-5A7E27E4-19E6-4A53-BBB1-4E6676979436Q37353651-1F88FAE2-BC2F-42D6-8D51-4C93A2ADF967Q37706033-D2CAE800-66E3-4506-9BB1-556A3037DB2EQ38639906-2A664A38-73B7-4D55-ABD0-5FDF4B39D13FQ42618281-41B8160F-B8A7-45BD-AF2B-FC77F3EEC007Q46565103-AF36CBE6-14B9-4999-B48E-CD16C70A5DF1
P2860
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@ast
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@en
type
label
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@ast
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@en
prefLabel
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@ast
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@en
P2860
P356
P1476
Atomoxetine reverses nicotine ...... contextual fear conditioning.
@en
P2093
Jennifer A Davis
Thomas J Gould
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301315
P407
P577
2007-01-17T00:00:00Z
P5875
P6179
1005326451